Can Wegovy HD 7.2 mg drive Novo Nordisk’s obesity drug rebound?
Novo Nordisk announced on Tuesday that it is making a higher-dose version of its popular weight-loss medication, Wegovy, available across the United States. The new 7.2-milligram dose, branded as Wegovy HD, was recently approved under the FDA Commissioner’s National Priority Review Voucher program last month, marking a significant development in obesity treatment options. Before this
